News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ex-SAC Trader Convicted Of Seeking Out Secrets Related To Experimental Alzheimer's Drug


2/7/2014 7:23:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Mathew Martoma had been on his way to being another American success story. Today, he is the eighth person who once worked for the hedge fund titan Steven A. Cohen to be convicted of insider trading. A federal jury in Manhattan on Thursday found Mr. Martoma guilty of seeking out confidential information related to a clinical trial for an experimental drug for Alzheimer’s disease — information that enabled Mr. Cohen’s SAC Capital Advisors to earn $275 million.

Help employers find you! Check out all the jobs and post your resume.

Read at New York Times
Read at Business Insider
Read at Forbes
Read at Wall Street Journal


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES